Journal of Inflammation Research (Jun 2021)

Pyroptosis: A New Regulating Mechanism in Cardiovascular Disease

  • Ji N,
  • Qi Z,
  • Wang Y,
  • Yang X,
  • Yan Z,
  • Li M,
  • Ge Q,
  • Zhang J

Journal volume & issue
Vol. Volume 14
pp. 2647 – 2666

Abstract

Read online

Nan Ji,1,2,* Zhongwen Qi,1,* Yueyao Wang,1 Xiaoya Yang,1 Zhipeng Yan,1 Meng Li,1 Qihui Ge,1 Junping Zhang1 1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300183, People’s Republic of China; 2National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 300193, People’s Republic of China*These authors contributed equally to this workCorrespondence: Junping Zhang Email [email protected]: Pyroptosis is a kind of pro-inflammatory cell death. Compared with autophagy and apoptosis, pyroptosis has unique characteristics in morphology and mechanism. Specifically, pyroptosis is a kind of cell lysis mediated by the Gasdermin family, releases inflammatory cytokines IL-1β and IL-18. There are three different forms of mechanism, which are caspase-1-mediated, caspase-4/5/11-mediated and caspase-3-mediated. A large number of studies have proved that pyroptosis is closely related to cardiovascular disease. This paper reviewed the recent progress in the related research on pyroptosis and myocardial infarction, ischemia-reperfusion, atherosclerosis, diabetic cardiomyopathy, arrhythmia, heart failure hypertension and Kawasaki disease. Therefore, we believe that pyroptosis may be a new therapeutic target in the cardiovascular field.Keywords: pyroptosis, cardiopathy, NLRP3, caspase-1, IL-1β

Keywords